Johnson & Johnson
I · KI-Analyse
Kurzfassung
J&J operates in two main areas: Innovative Medicine (prescription drugs for cancer, immunology, neuroscience, and other diseases) and MedTech (medical devices like surgical instruments, artificial joints, contact lenses under the ACUVUE brand, and robotic surgery systems) [Company Overview]. They sell to hospitals, doctors, pharmacies, and retailers worldwide [Company Overview].
Johnson & Johnson is a massive American healthcare company that makes both medicines (for cancer, immune diseases, etc.) and medical devices (surgical tools, contact lenses, artificial joints). With $96.4 billion in annual revenue and over 138,000 employees, it's one of the world's largest and most established healthcare firms [Company Overview].
Johnson & Johnson is in very strong financial shape with high profit margins and manageable debt.
Sentinellis-Score
10/10
Finanziell gesund
Marktkapitalisierung
$565,1B
Umsatz (12 Monate)
$96,4B
Erklärt
Wie wir diese Zahlen lesen
Verständliche Leitfäden · ohne Konto
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LesenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LesenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LesenII · Aktuelle Nachrichten
Was den Kurs bewegt hat
1 Meldung · nach Relevanz sortiert
- Makro2026-04-16
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.7% – Time to Sell?
Ticker Report
Premium · kostenlos mit jedem Konto
The Piotroski score of 3 out of 9 is concerning — this metric measures financial strength trends, and a low score suggests weakening fundamentals or operational efficiency compared to prior periods, though the specific drivers are not detailed in the data [Sentinellis calculation].
Risiken
3
Chancen
3
Warnsignale
2
Führung
10
7 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige Johnson & Johnson-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 3 Risiken, 3 Chancen und 2 Warnsignale — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
- PDF-Export für offline
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Gleicher Sektor · Gesundheitswesen — oder vergleichbare Finanzlage
Auf Ihre Watchlist setzen?